Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-19T00:00:34.399Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost-effectiveness analysis of two management strategies for dyspepsia

Published online by Cambridge University Press:  19 June 2007

Hans C. Kjeldsen ,
Mickael Bech  and
Bo Christensen
Hans C. Kjeldsen
Affiliation:
University of Aarhus and Institute of Public Health
Mickael Bech
Affiliation:
University of Southern Denmark
Bo Christensen
Affiliation:
University of Aarhus and Institute of Public Health
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: To compare the cost-effectiveness of endoscopy and empirical proton pump inhibition (PPI) therapy for management of dyspepsia in primary care.

Methods: A randomized controlled trial, including prospective collection of economic resource data, was conducted in general practice from June 2000 to August 2002, Aarhus County, Denmark. We randomly assigned 368 dyspeptic patients from thirty-two general practices to treatment with omeprazol 40 mg for 2 weeks (n=184) or endoscopy (n=184). The study adopted a societal perspective, and the year of costing was 2006. Outcome measures: days free of dyspeptic symptoms and proportion of patients with dyspepsia after 1 year based on patients' and general practitioners' (GPs) assessment. Costs were estimated from patient and GP questionnaires and from medical records.

Results: The incremental cost-effectiveness (CE) ratio for 1 day free of dyspeptic symptoms using the endoscopy strategy was €/day 154 compared with the PPI strategy. The incremental CE ratio for one person free of dyspeptic symptoms after 1 year using the endoscopy strategy was €13,905 based on the patients' evaluation, and the incremental CE ratio for one person free of predominant symptoms after 1 year was €5,990 according to the GPs' evaluation. The PPI strategy was both cheaper and more effective than the endoscopy strategy when reflux was the predominant symptom.

Conclusions: A strategy using empirical antisecretory PPI therapy should be recommended if the alternative is an endoscopy strategy for managing dyspeptic patients in general practice, especially if reflux was the predominant symptom.

Keywords

DyspepsiaHealthcare costsPrimary health careAntiulcer agentsHelicobacter pylori
Type
GENERAL ESSAYS
Information
International Journal of Technology Assessment in Health Care , Volume 23 , Issue 3 , July 2007 , pp. 376 - 384
Copyright
© 2007 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agreus L, Borgquist L. 2002 The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics. 20: 347– 355.Google Scholar
Bashford JN, Norwood J, Chapman SR. 1998 Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ. 317: 452– 456.Google Scholar
Bech M, Gyrd-Hansen D. 2000 Cost implications of routine mammography screening of women 50–69 years in the county of Funen, Denmark. Health Policy. 54: 125– 141.Google Scholar
Briggs AH, Wonderling DE, Mooney CZ. 1997 Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Econ. 6: 327– 340.Google Scholar
Bytzer P. 1999 Cost-effectiveness of gastroscopy. Ital J Gastroenterol Hepatol. 31: 749– 760.Google Scholar
Bytzer P, Hansen JM, Schaffalizky De Muckadell OB. 1994 Empirical H2-blocker therapy on prompt endoscopy in management of dyspepsia. Lancet. 343: 811– 816.Google Scholar
Bytzer P, Talley NJ. 2001 Dyspepsia. Ann Intern Med. 134: 815– 822.Google Scholar
Delaney B, Ford A, Forman D, et al. 2005; Initial management strategies for dyspepsia. Cochrane Database Syst Rev. CD001961.Google Scholar
Delaney B, Moayyedi P, Deeks J, et al. 2000 The management of dyspepsia: A systematic review. Health Technol Assess. 4: iii– 189.Google Scholar
Delaney BC, Wilson S, Roalfe A, et al. 2000 Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: A randomised controlled trial in primary care. Lancet. 356: 1965– 1969.Google Scholar
Ebell MH, Warbasse L, Brenner C. 1997 Evaluation of the dyspeptic patient: A cost-utility study. J Fam Pract. 44: 545– 555.Google Scholar
El-Serag HB, Talley NJ. 2004 Systemic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 19: 643– 654.Google Scholar
Fendrick AM, Chernew ME, Hirth RA, et al. 1995 Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 123: 260– 268.Google Scholar
Fenwick E, O'Brien BJ, Briggs A. 2004 Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 13: 405– 415.Google Scholar
Garcia-Altes A, Jovell E. 2001 Economic analysis of treatment of functional dyspepsia. An assessment of the quality of published studies. Int J Technol Assess Health Care. 17: 517– 527.Google Scholar
Gardner MJ, Altman DG. 1989: Estimation rather than hypothesis testing: Confidence intervals rather than P values. In: Gardner MJ, Altman DG, eds. Statistic with confidence. London: BMJ; 6– 19.
Gold MR, Siegel JE, Russell LB, et al. 1996. Cost-effectiveness in health and medicine. Oxford: Oxford University Press;
Heikkinen M, Pikkarainen P, Takala J, et al. 1996 General practitioners' approach to dyspepsia. Survey of consultation frequencies, treatment, and investigations. Scand J Gastroenterol. 31: 648– 653.Google Scholar
Hirth RA, Bloom BS, Chernew ME, et al. 2000 Patient, physician, and payer perceptions and misperceptions of willingness to pay for diagnostic certainty. Int J Technol Assess Health Care. 16: 35– 49.Google Scholar
Huang J, Lam SK, Malfertheiner P, et al. 2003 Has education about Helicobacter pylori infection been effective? Worldwide survey of primary care physicians. J Gastroenterol Hepatol. 18: 512– 520.Google Scholar
Kjeldsen HC. 2005. Dyspepsia in general practice—Reasons to consult, management strategies and health economic consequences. Aarhus: Faculty of Health Science, University of Aarhus;
Kristiansen IS, Gyrd-Hansen D. 2004; Cost-effectiveness analysis based on the number-needed-to-treat: Common sense or non-sense? Health Econ. 13: 9– 19.Google Scholar
Laheij RJ, Severens JL, Jansen JB, et al. 1997 Management in general practice of patients with persistent dyspepsia. A decision analysis. J Clin Gastroenterol. 25: 563– 567.Google Scholar
Laheij RJ, Severens JL, Van de Lisdonk EH, et al. 1998 Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: A cost-effectiveness analysis. Aliment Pharmacol Ther. 12: 1249– 1256.Google Scholar
Lassen AT, Hallas J, Schaffalitzky de Muckadell OB. 2004 Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut. 53: 1758– 1763.Google Scholar
Lewin-Van Den Broek NT. 1999. Diagnostic and therapeutic strategies. Utrecht: University Utrecht;
Makris N, Barkun A, Crott R, et al. 2003 Cost-effectiveness of alternative approaches in the management of dyspepsia. Int J Technol Assess Health Care. 19: 446– 464.Google Scholar
Mandelblatt JS, Fryback DG, Weinstein MC, et al. 1997 Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine. J Gen Intern Med. 12: 551– 558.Google Scholar
Martin RM, Lim AG, Kerry SM, et al. 1998 Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care. Aliment Pharmacol Ther. 12: 797– 805.Google Scholar
Nyren O, Lindberg G, Lindstrom E, et al. 1992 Economic costs of functional dyspepsia. Pharmacoeconomics. 1: 312– 324.Google Scholar
Ofman JJ, Rabeneck L. 1999 The effectiveness of endoscopy in the management of dyspepsia: A qualitative systematic review. Am J Med. 106: 335– 346.Google Scholar
Posnett J, Jan S. 1996 Indirect cost in economic evaluation: The opportunity cost of unpaid inputs. Health Econ. 5: 13– 23.Google Scholar
Schwartz LM, Woloshin S, Welch HG. 1996 Trends in diagnostic testing following a national guideline for evaluation of dyspepsia. Arch Intern Med. 156: 873– 875.Google Scholar
Scott BB. 1995 Gastroenterology in the Trent Region in 1992 and a review of changes since 1975. Gut. 36: 468– 472.Google Scholar
Sculpher M. 2001: The role and estimation of productivity costs in economic evaluation. In: Drummond M, McGuire A, eds. Economic evaluation in health care merging theory with practice. Oxford: Oxford University Press; 94– 112.
Severens JL, Laheij RJ, Jansen JB, et al. 1998 Estimating the cost of lost productivity in dyspepsia. Aliment Pharmacol Ther. 12: 919– 923.Google Scholar
Silverstein MD, Petterson T, Talley NJ. 1996 Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis. Gastroenterology. 110: 72– 83.Google Scholar
Spiegel BM, Vakil NB, Ofman JJ. 2002 Dyspepsia management in primary care: A decision analysis of competing strategies. Gastroenterology. 122: 1270– 1285.Google Scholar
Talley NJ, Colin-Jones DG, Koch KL, et al. 1991: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterology. 145– 160.Google Scholar
Westbrook JI. 2002 Trends in the utilization of diagnostic upper GI endoscopy in New South Wales, Australia, 1988 to 1998. Gastrointest Endosc. 55: 847– 853.Google Scholar
Westbrook JI, Duggan AE, McIntosh JH. 2001 Prescriptions for antiulcer drugs in Australia: Volume, trends, and costs. BMJ. 323: 1338– 1339.Google Scholar
Westbrook JI, Rushworth RL, Rob MI, et al. 1993 Diagnostic procedures and health outcomes. Upper gastrointestinal tract investigations in the elderly. Med J Aust. 159: 242– 245.Google Scholar